Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL StudyAlex Y. Chang, Nick Thatcher, Chao‐Jung Tsao et al.|Journal of Thoracic Oncology|2006Cited by 168
Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL StudyAlex Y. Chang, Nick Thatcher, Purvish M. Parikh et al.|Journal of Thoracic Oncology|2006Cited by 129
Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON IIIJane Robertson, Hans‐Joachim Schmoll, Mace L. Rothenberg et al.|Clinical Colorectal Cancer|2009Cited by 42